human polymorphonuclear neutrophil responses to ... · 27/10/2008 · diabetic thai subjects. the...
TRANSCRIPT
1
Human Polymorphonuclear Neutrophil Responses to Burkholderia
pseudomallei in Healthy and Diabetic Subjects
Sujin Chanchamroen1, Chidchamai Kewcharoenwong
1, Wattanachai Susaengrat
2, 5
Manabu Ato3, and Ganjana Lertmemongkolchai
1*
1The Center for Research and Development of Medical Diagnostic Laboratories,
Faculty of Associated Medical Sciences, Khon Kaen University, 2Department of
Medicine, Khon Kaen Hospital, Ministry of Public Health, Thailand. 3Department of 10
Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Running head: Human PMN responses to B. pseudomallei
*Corresponding author. Mailing address: Center for Research and Development in 15
Medical Diagnostic Laboratories (CMDL), Faculty of Associated Medical Sciences,
Khon Kaen University, Khon Kaen, Thailand. Phone: +66 4320 3825. Fax: +66 4320
3826. E-mail: [email protected]
ACCEPTED
Copyright © 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.Infect. Immun. doi:10.1128/IAI.00503-08 IAI Accepts, published online ahead of print on 27 October 2008
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
2
Abstract
The major predisposing factor to melioidosis is diabetes mellitus but no
immunological mechanisms have been investigated to explain this. In this study,
polymorphonuclear neutrophil (PMN) responses to Burkholderia pseudomallei, the
causative agent of melioidosis, were determined by flow cytometry in healthy and 5
diabetic Thai subjects. The results showed that B. pseudomallei displayed reduced
PMN uptake as compared to Salmonella enterica serovar Typhimurium and
Escherichia coli. Additionally, intracellular survival of B. pseudomallei was detected
throughout the 24 h period, indicating the intrinsic resistance of B. pseudomallei to
killing by PMNs. Moreover, PMNs from diabetic subjects displayed impaired 10
phagocytosis of B. pseudomallei, reduced migration in response to IL-8 and inability
to delay apoptosis. These data show that B. pseudomallei is intrinsically resistant to
phagocytosis and killing by PMNs. These observations, together with the impaired
migration and apoptosis in diabetes mellitus, may explain host susceptibility in
melioidosis. 15
Key words: B. pseudomallei; Melioidosis; Diabetes mellitus; PMN functions
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
3
Introduction
Melioidosis is a serious infectious disease caused by the Gram-negative
bacillus, Burkholderia pseudomallei, and is endemic in northern Australia and
Southeast Asia, particularly northeast Thailand (4, 44). Infection occurs by
subcutaneous inoculation of contaminated soil, surface water or inhalation. The 5
clinical features vary from acute fulminant septicemia to chronic debilitating localized
infection. Therapeutic treatment is difficult and, even with recent improvements in
diagnosis and antibiotic regimens, the mortality rate associated with severe
melioidosis remains high at up to 50% (17). Moreover, recurrence of infection is
common despite adequate antimicrobial therapy (18). The risk factors for developing 10
melioidosis have been defined in several studies. Diabetes mellitus (DM), renal
diseases (renal calculi or renal failure), thalassemia and occupational exposure to
surface water are associated with an increased risk of melioidosis (4, 35).
Patients with diabetes mellitus, in particular, have a high incidence of
melioidosis, with up to 60% of patients having preexisting or newly diagnosed type 2 15
diabetes. The review of case records of 1,817 Thai patients with melioidosis revealed
that fewer than 10% of 382 patients with diabetes mellitus were insulin dependent or
had type I diabetes (31). However, no studies have been performed on the immune
functions of Thai diabetics with respect to B. pseudomallei.
In general, polymorphonuclear neutrophils (PMNs) play an important role in 20
the host inflammatory response against infection. Clinical investigations in subjects
who have diabetes mellitus and experimental studies in diabetic rats and mice clearly
demonstrate consistent defects of PMN chemotactic (12), phagocytic (19) and
antimicrobicidal activities (21). Up to now, the contribution of human PMNs to
resistance to B. pseudomallei infection has not been directly addressed, but indirect 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
4
evidence suggests that they may play an important role in melioidosis. For example, a
previous study in Darwin, Australia that compared melioidosis patients who received
granulocyte colony-stimulating factor (G-CSF) with control subjects showed the
mortality rate decreased from 95% to 10% after the introduction of G-CSF (5). More
recently, a randomized controlled trial of G-CSF for the treatment of severe sepsis due 5
to melioidosis in Thailand resulted in a longer duration of host survival (6). These
results suggested the host benefit associated with G-CSF treatment that could involve
PMNs. Unfortunately, an in vitro whole blood assay was unable to explore the
mechanism of G-CSF action in the treatment of B. pseudomallei infection (5).
Additionally, it has been demonstrated in a murine model that the resistance against B. 10
pseudomallei infection is critically dependent on PMNs (9).
In this study, human PMN responses to B. pseudomallei, particularly in
diabetic Thai subjects who lived in an endemic area of melioidosis, were determined
in terms of bacterial killing, phagocytosis, migration and apoptosis.
15 ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
5
Materials and Methods
Human subjects
Forty-six diabetic and 26 healthy Thai subjects were enrolled into this study.
Diabetic subjects were defined as individuals who had preexisting diabetes mellitus 5
and were treated at the diabetes mellitus clinic, Outpatient Department, Khon Kaen
Hospital. Healthy subjects who lived in Khon Kaen, northeastern Thailand and had
normal blood counts, normal fasting blood glucose, and normal glycosylated
hemoglobin A1c (HbA1c) constituted the healthy control group. HbA1c is
glycosylated hemoglobin, which reflects the average blood glucose levels over the 10
previous 2–3 months and is generally used to monitor the degree of glycemic control
at DM clinics. In this study, DM subjects were defined as having good, poor or very
poor glycemic controls by the levels of HbA1c (5.5–7.5, 7.6–8.5 and greater than
8.5%, respectively). Characteristics of subjects are shown in Table 1. All were rice
farmers who were at risk of melioidosis, with no signs of acute infectious diseases 15
during the previous 3 months and at the time of the study. Any subjects with impaired
renal function defined by serum creatinine ≥ 2.0 mg/dl were excluded. The study was
reviewed and approved by the Khon Kaen University Ethics Committee for Human
Research and Khon Kaen Hospital Ethics committee. Written informed consent was
obtained from all study subjects. 20
Growth of bacteria
B. pseudomallei strain K96243 is the prototype strain for which the genome
sequence was derived. Salmonella enterica serovar Typhimurium and Escherichia
coli are clinical isolates that have been used extensively by our laboratory. The
bacteria were grown in Luria-Bertani (LB) broth for 18 h at 37°C, washed twice with 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
6
PBS pH7.4, aliquoted and stored at −80°C. The number of viable bacteria was
determined by colony-forming counts and defined as colony-forming units (CFU)
prior to use. Live B. pseudomallei was handled under the Center for Disease Control
(CDC) regulations for biosafety containment level 3.
Labeling of bacteria with FITC 5
B. pseudomallei, S. Typhimurium and E. coli at 1×108 CFU/ml were incubated
with 1 µg/ml fluorescein isothiocyanate (FITC; Sigma, USA) in the dark at room
temperature for 60 min and analyzed for FITC intensity prior to use. FITC-labeled
bacteria were used in the experiment once only and discarded.
PMN isolation 10
Human PMNs were isolated from heparinized venous blood by 3.0% Dextran
T-500 sedimentation and Ficoll-PaquePLUS centrifugation (Amersham Biosciences,
UK). In all experiments, PMN purity was > 95%, as determined by Giemsa stain and
microscopy, while cell viability was > 98% as determined by trypan blue exclusion
(11). 15
Intracellular survival and replication of B. pseudomallei in human PMNs
Purified PMNs in RPMI 1640 were infected with B. pseudomallei at
Multiplicity of Infection (MOI) of 0.3:1 at 37°C for 30 min. Intracellular survival of
B. pseudomallei in PMNs was determined after the extracellular bacteria were killed
with 250 µg/ml kanamycin at 37°C for 30 minutes and culture supernatants were 20
checked for sterility by plating on LB agar plates.
Phagocytosis and oxidative burst assayed by flow cytometry
Diluted whole blood samples were stimulated in vitro with FITC-labeled
bacteria at MOI of 10:1 for 60 min or 800 ng/ml phorbol 12-myristate 13-acetate
(PMA; Sigma, USA) for 15 min at 37ºC, and 25 µl of 2800 ng/ml hydroethidine (HE; 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
7
Sigma, USA) was added for a further 5 min at 37ºC. Erythrocytes were then lysed by
lysing buffer (BD Biosciences, USA), washed twice and fixed with 10%
paraformaldehyde for decontamination prior to analysis by flow cytometry
(FACSCalibur; BD Biosciences, USA) (24, 26, 43).
Determination of PMN migration 5
Purified PMNs at 5 × 106 cells/ml were incubated in the upper chamber of 3
µm pore Transwell plates (Corning Life sciences, Australia), and 20–100 ng/ml of
recombinant IL-8 (PeproTec, UK) were placed in the lower 0.5 ml chamber at 37°C
for 1 h. Transmigrated PMNs in the lower chamber were counted by flow cytometry
(FACSCalibur; BD Biosciences, USA), the migration index was calculated as: 10
number of transmigrated PMNs in response to IL-8/ number of transmigrated PMNs
in response to medium control (10). In some experiments, purified PMNs were
stimulated with intact heat killed B. pseudomallei at MOI of 1:1 or 1:10, at 37°C for 1
h prior to testing for migration.
PMN apoptosis assayed by flow cytometry 15
Apoptosis of PMNs was determined by flow cytometry using an annexin V
binding assay. Purified PMNs were cultured with medium alone or B. pseudomallei at
MOI of 1:1, 37ºC for 24 h. Intracellular survival of B. pseudomallei was quantified by
colony plating as described in the intracellular survival and replication assay. At the
indicated time points, cells were collected, washed with annexin V staining buffer (pH 20
7.4) and labeled with allophycocyanin (APC)-conjugated annexin V (BD Biosciences,
USA) for 15 min at room temperature. After washing, cells were fixed with 10%
paraformaldehyde and analyzed by flow cytometry (FACSCalibur; BD Biosciences,
USA) (8). In other experiments with heat-killed B. pseudomallei, propidium iodide
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
8
(BD Biosciences, USA) was included with APC-conjugated annexin V and there was
no fixation step prior to analysis by flow cytometry.
Statistical analysis
Statistical analysis (Mann-Whitney test and paired t test) was performed by
Graphpad PRISM statistical software (GraphPad, San Diego, USA). A P value of < 5
0.05 was considered to be statistically significant.
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
9
Results
Resistance of B. pseudomallei to phagocytosis and killing by human PMNs
We first monitored the intracellular survival of B. pseudomallei in PMNs. As
shown in Figure 1, after the initial 1 h of incubation (T0), the percentages of initial
inoculum of B. pseudomallei in diabetic PMNs (average 0.7%) was lower than that of 5
healthy PMNs (average 11.9%), even though it was not statistically significant (Mann
Whitney test, P> 0.05). After an additional 1 h of incubation, the numbers of
intracellular bacteria decreased 10–100-fold in PMN cells of both groups, but viable
B. pseudomallei could still be detected at 24 h. These results suggested that PMNs
from both healthy and DM groups can kill the majority of bacteria, but some B. 10
pseudomallei survive within human PMNs.
We then measured the uptake of B. pseudomallei by human PMNs in
comparison with other Gram negative bacteria, S. Typhimurium and E. coli by flow
cytometry. The results showed that B. pseudomallei was less efficiently phagocytosed
by PMNs than S. Typhimurium and E. coli (paired t test, P < 0.005) in both healthy 15
and diabetic groups (Figure 2). In addition, heat-killed B. pseudomallei, S.
Typhimurium and E. coli were assayed in the same condition and the results
confirmed the important finding that B. pseudomallei was phagocytosed by PMNs at a
lower rate than the other species (data not shown).
Poor glycemic control impaired B. pseudomallei phagocytosis 20
We next investigated whether the degree of glycemic control, as monitored by
percentage of glycosylated hemoglobin A1c (HbA1c) in DM, influenced the
antimicrobial activities of PMNs following encounter with B. pseudomallei. DM
subjects were classified into good, poor and very poor glycemic control by the levels
of HbA1c (5.5–7.5, 7.6–8.5, and above 8.5%, respectively). Firstly, phagocytosis of 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
10
B. pseudomallei and oxidative burst by PMNs from diabetic and healthy subjects were
assessed as described above. Phagocytosis of B. pseudomallei was significantly
impaired in very poor glycemic control diabetic subjects (HbA1c>8.5%) when
compared with healthy subjects (Mann-Whitney test, P < 0.05) (Figure 3A and B).
Moreover, these results were in agreement with those obtained from our intracellular 5
survival assays suggesting that phagocytosis of B. pseudomallei from diabetic PMNs
were impaired in parallel with poor glycemic control. In addition, oxidative burst
induced by B. pseudomallei also tended to be impaired although this was not
statistically significant at 95% confidence interval (Mann-Whitney test, P = 0.0545)
while PMA induction was comparable between healthy and DM subjects (Figure 3A, 10
C and D). These results suggest that the extent of glycemic control influences the
impairment of PMN phagocytosis of B. pseudomallei, and might also affect the PMN
killing function via the oxidative burst.
Diabetic PMNs reduced migration in responses to interleukin-8 and this was
inhibited by intact B. pseudomallei 15
PMN migration in response to IL-8, a major chemokine responsible for this
function, was assessed in both subject groups. The results showed that PMNs from
diabetic subjects tended to reduce migration in responses to IL-8 in all doses that we
used when compared with healthy subjects (Figure 4A).
In other septic or bacteremic models of infection, pathogens are already in the 20
host system and several lines of evidence suggest that pathogens can interfere with
host immune responses. To investigate whether this PMN migration in response to IL-
8 could be altered upon encountering with B. pseudomallei, purified PMNs from five
healthy and five diabetic subjects were incubated with intact heat killed B.
pseudomallei at MOI of 1:1, 10:1 and 100:1 at 37ºC for 1 h. Then, stimulated PMNs 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
11
were collected and tested for migration activity. Interestingly, the migration index of
B. pseudomallei stimulated PMNs was decreased when the numbers of B.
pseudomallei were increased (Figure 4B). These observations were significantly
demonstrated in healthy and DM subjects (paired t test, P < 0.005 and < 0.05,
respectively) suggesting that B. pseudomallei was capable of interfering with PMN 5
migration in both healthy and diabetic subjects.
B. pseudomallei decreased PMN apoptosis/necrosis
After phagocytosis, PMNs normally undergo apoptosis resulting in being
engulfed by macrophages but it has been reported in other pathogens such as
Anaplasma phagocytophilum (8), Leishmania major (1) and Chlamydia pneumoniae 10
(40) that these organisms could delay the spontaneous apoptosis of human PMNs. To
assess PMN apoptosis/necrosis after exposure to B. pseudomallei, purified PMNs
were incubated with live B. pseudomallei at MOI of 1:1 and analyzed for the kinetics
of annexin V positive PMNs at 0, 1, 3, 16 and 24 h post infection (Figure 5A). The
results showed that annexin V positive PMNs were clearly detected at 16 h and still 15
raised at 24 h, therefore this 24 h time point was selected for further studies in healthy
vs. DM subjects.
After the initial 1 h of incubation (T0), diabetic PMNs attained similar levels
of apoptosis/necrosis compared with healthy PMNs in the absence or presence of live
B. pseudomallei (Figure 5B). At 24 h of incubation (T24), the percentages of 20
spontaneous apoptotic/necrotic PMNs from healthy subjects were statistically reduced
in the presence of B. pseudomallei (paired t test, P < 0.05). However, this
phenomenon was not observed in diabetic subjects (paired t test, P > 0.05) (Figure
5C). These results indicated that live B. pseudomallei interfered with the spontaneous
apoptosis/necrosis of PMNs in healthy but not diabetic subjects. 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
12
In addition, heat-killed bacteria were used to replace live B. pseudomallei
under the same conditions and PMNs were stained for annexin V and propidium
iodide (PI) (Figure 5D). The results showed that apoptotic PMNs, defined by annexin
V positive and PI negative cells were significantly decreased when compared with
medium alone (paired t test, P < 0.05 and < 0.005 in healthy and DM subjects, 5
respectively) (Figure 5E). These results indicated that apoptosis is a major event
during this 24 h with small numbers of necrotic cells (annexin V positive and PI
positive) and increasing MOI from 1:1 to 10:1 did not significantly change the
percentage of annexin V positive cells (data not shown). However, the mechanisms of
B. pseudomallei interference on PMN functions requires further investigation. 10
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
13
Discussion
PMNs are the first line of host resistance against bacterial infection. The main
mechanisms that allow microbial killing are migration of PMNs to the site of
infection, phagocytosis and killing by both oxygen dependent and independent
mechanisms (20, 38). In addition, activated PMNs produce chemokines and cytokines 5
which recruit and activate other immune cells (38). Finally, activated PMNs undergo
apoptosis (16) resulting in phagocytosis by macrophages (41).
In this study, we have provided evidence that B. pseudomallei was
phagocytosed by PMNs at a lower rate than other Gram negative bacteria such as S.
Typhimurium and E. coli suggesting that B. pseudomallei might have antiphagocytic 10
activity; further studies are required to corroborate this conclusion. To avoid the
possible effects of varying bacterial doubling time, heat-killed bacteria of the three
pathogens were also studied and the results were consistent with the previous
observation with live bacteria indicating the distinctive character of the PMN–B.
pseudomallei interaction. However, the resistance to phagocytosis by other pathogens 15
involves several steps in the process of phagocytosis such as evasion of binding and
ingestion by interference with complement function. In B. pseudomallei infection, it
has been shown that capsular polysaccharide of this organism contributes to the
resistance to in vitro phagocytosis by reducing C3b deposition on the bacterial surface
(29). 20
Other mechanisms have been reported in Yersinia enterocolitica resistance to
phagocytosis: two adhesins, Inv and YadA, and the type III secretion systems
including effector proteins (7, 13, 42). These Yersinia effectors, which are referred to
as Yops (Yersinia outer proteins) are involved in inhibition of phagocytosis (13) and
YopT, which is an essential part of the antiphagocytic strategy, has been shown to 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
14
disturb actin cytoskeleton (14, 30). Several reports have identified similar type III
secretion systems in B. pseudomallei contributing to bacterial virulence including
bipD, bipB and bopE (23, 32–34). However, type III secretion systems are unlikely to
be solely responsible for an antiphagocytic effect on the basis that it is an active
process that can be expected to be absent in heat inactivated bacteria. 5
Previous studies have documented the intracellular persistence of B.
pseudomallei; for example, B. pseudomallei triggered a poor killing mechanism (11,
27), PMNs were not capable of killing B. pseudomallei in the presence of 10% normal
serum (28) and the growth of B. pseudomallei was detected in PMNs after extended
incubation (15, 27). In our study, intracellular survival of B. pseudomallei in purified 10
PMNs was observed after extended incubation, consistent with the latter finding.
However, MOI ratio may affect the outcome of PMN functional assays, as in the other
studies, MOI varied from 4:1 to 100:1. We have used 0.3:1 and the result showed that
B. pseudomallei was still resistant to killing by human PMNs. In addition, it has been
demonstrated that B. pseudomallei is susceptible to the bactericidal effects of both 15
reactive nitrogen intermediate (RNI) and reactive oxygen intermediate (ROI) in a cell-
free system in vitro (22). The resistance of B. pseudomallei to the antimicrobial
activity of defensins may also facilitate intracellular survival in PMNs (15).
The major risk factor associated with severe melioidosis is diabetes mellitus
(35). One simple explanation is that innate immunity of diabetic patients, particularly 20
PMN functions is altered (2, 3, 36). Our study has demonstrated that diabetes mellitus
subjects have reduced PMN migration in response to IL-8 when compared with
healthy subjects. This may result in the delayed accumulation of PMNs at the site of
infection. Moreover, B. pseudomallei is a poor activator of IL-8 production from
human lung epithelial cell line A549 when compared with other Gram negative 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
15
bacteria such as Salmonella enterica serovar Typhi (39). These findings suggest that
the signals initiated by the interaction of B. pseudomallei with epithelium cells at the
site of infection might not be sufficient for diabetic PMN recruitment.
In addition, diabetic PMNs exhibit reduced phagocytosis of B. pseudomallei in
poor glycemic control diabetic subjects. This is consistent with the result obtained 5
from intracellular survival assays that internalization of B. pseudomallei by diabetic
PMNs tended to be lower than that by PMNs from healthy subjects. A similar finding
has been reported in patients with poor glycemic control who showed impaired PMN
phagocytosis of virulent K1/K2 K. pneumoniae compared with patients with good
glycemic control and healthy volunteers (19). Therefore, persistently poor glycemic 10
control could have a progressively deleterious effect on phagocytic function. Further
investigation to reveal the mechanisms utilized by B. pseudomallei in antiphagocytic
activity and reduced PMN migration will be important. In addition, there was a trend
for the worst glycemic control DM subjects to display lower oxidative bursts in
response to B. pseudomallei and further studies are needed to address this observation 15
in more detail.
In the PMN apoptosis assay, B. pseudomallei infected PMNs from healthy
subjects delayed spontaneous apoptosis/necrosis up to 24 h while this phenomenon
was not significantly observed in diabetic subjects. It is not clear why the difference
has occurred. However, the delay of PMN apoptosis was significantly demonstrated 20
with heat-killed bacteria in both healthy and DM subjects, such a delay may favor
bacterial survival. A recent report demonstrated that PMNs produced their own
survival factors including cytokines and decreased Bax-α/Bcl-xL ratio during the early
steps of other infections when the number of bacteria was still low (25). PMN survival
may be extended in order to accomplish their functional activity in innate immunity. 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
16
The reduced ability of diabetic PMNs to delay apoptosis following B. pseudomallei
exposure could result in the decrease of functional longevity of PMNs and increased
PMN clearance from the infectious sites. This would be consistent with previous data
which showing that diabetic PMNs underwent normal spontaneous apoptosis and did
not demonstrate LPS-induced inhibition of apoptosis (37). 5
Taken together, our results suggest that PMNs of diabetic subjects could be
defective within the early phase (24 h) of the inflammatory response against B.
pseudomallei. The alterations included not only migration, phagocytosis and apoptosis
but possibly also the killing mechanism via oxidative burst. Our experiments are the
first to directly address the immunological basis of diabetes as a major risk factor for 10
melioidosis. We believe that the impaired neutrophil functions of Thai diabetics with
poor glycemic control could contribute to their increased susceptibility to this
important disease.
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
17
Acknowledgements
We thank Drs Gregory J. Bancroft and Mark P. Stevens for their critical
comments and reviewing the manuscript, Dr Debbie Smith, Ms Heidi Alderton and Dr
Jon Cuccui from the London School of Hygiene and Tropical Medicine, UK for
providing the training on biohazard containment level 3 at CMDL, Khon Kaen 5
University, Thailand and Ms Vicki Harley for her editorial help in preparing this
manuscript. This work was supported in part by Public Health Service Grant U01
AI061363 from the National Institute of Allergy and Infectious Diseases, USA.
10
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
18
References
1. Aga, E., D. M. Katschinski, G. van Zandbergen, H. Laufs, B. Hansen, K.
Muller, W. Solbach, and T. Laskay. 2002. Inhibition of the spontaneous
apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania
major. J Immunol 169:898–905. 5
2. Alba-Loureiro, T. C., S. M. Hirabara, J. R. Mendonca, R. Curi, and T. C.
Pithon-Curi. 2006. Diabetes causes marked changes in function and
metabolism of rat neutrophils. J Endocrinol 188:295–303.
3. Alba-Loureiro, T. C., C. D. Munhoz, J. O. Martins, G. A. Cerchiaro, C.
Scavone, R. Curi, and P. Sannomiya. 2007. Neutrophil function and 10
metabolism in individuals with diabetes mellitus. Braz J Med Biol Res
40:1037–1044.
4. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology,
pathophysiology, and management. Clin Microbiol Rev 18:383–416.
5. Cheng, A. C., P. Dasari, and B. J. Currie. 2004. Granulocyte colony-15
stimulating factor and an in vitro whole blood model of melioidosis. Eur J Clin
Microbiol Infect Dis 23:205–207.
6. Cheng, A. C., D. Limmathurotsakul, W. Chierakul, N. Getchalarat, V.
Wuthiekanun, D. P. Stephens, N. P. Day, N. J. White, W. Chaowagul, B.
J. Currie, and S. J. Peacock. 2007. A randomized controlled trial of 20
granulocyte colony-stimulating factor for the treatment of severe sepsis due to
melioidosis in Thailand. Clin Infect Dis 45:308–314.
7. China, B., B. T. N'Guyen, M. de Bruyere, and G. R. Cornelis. 1994. Role
of YadA in resistance of Yersinia enterocolitica to phagocytosis by human
polymorphonuclear leukocytes. Infect Immun 62:1275–1281. 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
19
8. Choi, K. S., J. T. Park, and J. S. Dumler. 2005. Anaplasma
phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-
activated protein kinase signal pathway. Infect Immun 73:8209–8218.
9. Easton, A., A. Haque, K. Chu, R. Lukaszewski, and G. J. Bancroft. 2007.
A critical role for neutrophils in resistance to experimental infection with 5
Burkholderia pseudomallei. J Infect Dis 195:99–107.
10. Edwards, R. J., G. W. Taylor, M. Ferguson, S. Murray, N. Rendell, A.
Wrigley, Z. Bai, J. Boyle, S. J. Finney, A. Jones, H. H. Russell, C. Turner,
J. Cohen, L. Faulkner, and S. Sriskandan. 2005. Specific C-terminal
cleavage and inactivation of interleukin-8 by invasive disease isolates of 10
Streptococcus pyogenes. J Infect Dis 192:783–790.
11. Egan, A. M., and D. L. Gordon. 1996. Burkholderia pseudomallei activates
complement and is ingested but not killed by polymorphonuclear leukocytes.
Infect Immun 64:4952–4959.
12. Golub, L. M., G. A. Nicoll, V. J. Iacono, and N. S. Ramamurthy. 1982. In 15
vivo crevicular leukocyte response to a chemotactic challenge: inhibition by
experimental diabetes. Infect Immun 37:1013–1020.
13. Grosdent, N., I. Maridonneau-Parini, M. P. Sory, and G. R. Cornelis.
2002. Role of Yops and adhesins in resistance of Yersinia enterocolitica to
phagocytosis. Infect Immun 70:4165–4176. 20
14. Iriarte, M., and G. R. Cornelis. 1998. YopT, a new Yersinia Yop effector
protein, affects the cytoskeleton of host cells. Mol Microbiol 29:915–929.
15. Jones, A. L., T. J. Beveridge, and D. E. Woods. 1996. Intracellular survival
of Burkholderia pseudomallei. Infect Immun 64:782–790.
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
20
16. Kobayashi, S. D., K. R. Braughton, A. R. Whitney, J. M. Voyich, T. G.
Schwan, J. M. Musser, and F. R. DeLeo. 2003. Bacterial pathogens
modulate an apoptosis differentiation program in human neutrophils. Proc Natl
Acad Sci U S A 100:10948–10953.
17. Leelarasamee, A. 2004. Recent development in melioidosis. Curr Opin Infect 5
Dis 17:131–136.
18. Limmathurotsakul, D., W. Chaowagul, W. Chierakul, K. Stepniewska, B.
Maharjan, V. Wuthiekanun, N. J. White, N. P. Day, and S. J. Peacock.
2006. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect
Dis 43:979–986. 10
19. Lin, J. C., L. K. Siu, C. P. Fung, H. H. Tsou, J. J. Wang, C. T. Chen, S. C.
Wang, and F. Y. Chang. 2006. Impaired phagocytosis of capsular serotypes
K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor
glycemic control. J Clin Endocrinol Metab 91:3084–3087.
20. Mayer-Scholl, A., P. Averhoff, and A. Zychlinsky. 2004. How do 15
neutrophils and pathogens interact? Curr Opin Microbiol 7:62–66.
21. Mazade, M. A., and M. S. Edwards. 2001. Impairment of type III group B
Streptococcus-stimulated superoxide production and opsonophagocytosis by
neutrophils in diabetes. Mol Genet Metab 73:259–267.
22. Miyagi, K., K. Kawakami, and A. Saito. 1997. Role of reactive nitrogen and 20
oxygen intermediates in gamma interferon-stimulated murine macrophage
bactericidal activity against Burkholderia pseudomallei. Infect Immun
65:4108–4113.
23. Moore, R. A., S. Reckseidler-Zenteno, H. Kim, W. Nierman, Y. Yu, A.
Tuanyok, J. Warawa, D. DeShazer, and D. E. Woods. 2004. Contribution 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
21
of gene loss to the pathogenic evolution of Burkholderia pseudomallei and
Burkholderia mallei. Infect Immun 72:4172–4187.
24. O'Gorman, M. R., and V. Corrochano. 1995. Rapid whole-blood flow
cytometry assay for diagnosis of chronic granulomatous disease. Clin Diagn
Lab Immunol 2:227–232. 5
25. Ocana, M. G., V. Asensi, A. H. Montes, A. Meana, A. Celada, and E.
Valle-Garay. 2008. Autoregulation mechanism of human neutrophil apoptosis
during bacterial infection. Mol Immunol 45:2087–2096.
26. Perticarari, S., G. Presani, and E. Banfi. 1994. A new flow cytometric assay
for the evaluation of phagocytosis and the oxidative burst in whole blood. J 10
Immunol Methods 170:117–124.
27. Pruksachartvuthi, S., N. Aswapokee, and K. Thankerngpol. 1990. Survival
of Pseudomonas pseudomallei in human phagocytes. J Med Microbiol
31:109–114.
28. Razak N, I. G. 1982. Interaction of human polymorphonuclear leukocytes 15
with Pseudomonas pseudomallei. J Gen Appl Microbiol 28:509–518.
29. Reckseidler-Zenteno, S. L., R. DeVinney, and D. E. Woods. 2005. The
capsular polysaccharide of Burkholderia pseudomallei contributes to survival
in serum by reducing complement factor C3b deposition. Infect Immun
73:1106–1115. 20
30. Shao, F., P. O. Vacratsis, Z. Bao, K. E. Bowers, C. A. Fierke, and J. E.
Dixon. 2003. Biochemical characterization of the Yersinia YopT protease:
cleavage site and recognition elements in Rho GTPases. Proc Natl Acad Sci U
S A 100:904–909.
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
22
31. Simpson, A. J., P. N. Newton, W. Chierakul, W. Chaowagul, and N. J.
White. 2003. Diabetes mellitus, insulin, and melioidosis in Thailand. Clin
Infect Dis 36:e71–72.
32. Stevens, J. M., E. E. Galyov, and M. P. Stevens. 2006. Actin-dependent
movement of bacterial pathogens. Nat Rev Microbiol 4:91–101. 5
33. Stevens, M. P., M. W. Wood, L. A. Taylor, P. Monaghan, P. Hawes, P. W.
Jones, T. S. Wallis, and E. E. Galyov. 2002. An Inv/Mxi-Spa-like type III
protein secretion system in Burkholderia pseudomallei modulates intracellular
behaviour of the pathogen. Mol Microbiol 46:649–659.
34. Suparak, S., W. Kespichayawattana, A. Haque, A. Easton, S. Damnin, G. 10
Lertmemongkolchai, G. J. Bancroft, and S. Korbsrisate. 2005.
Multinucleated giant cell formation and apoptosis in infected host cells is
mediated by Burkholderia pseudomallei type III secretion protein BipB. J
Bacteriol 187:6556–6560.
35. Suputtamongkol, Y., W. Chaowagul, P. Chetchotisakd, N. 15
Lertpatanasuwun, S. Intaranongpai, T. Ruchutrakool, D. Budhsarawong,
P. Mootsikapun, V. Wuthiekanun, N. Teerawatasook, and A. Lulitanond.
1999. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis
29:408–413.
36. Suzanne E. Geerlings, A. I. M. H. 1999. Immune dysfunction in patients 20
with diabetes mellitus (DM). FEMS Immunology and Medical Microbiology
26:259–265.
37. Tennenberg, S. D., R. Finkenauer, and A. Dwivedi. 1999. Absence of
lipopolysaccharide-induced inhibition of neutrophil apoptosis in patients with
diabetes. Arch Surg 134:1229–1233; discussion 1233–1224. 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
23
38. Theilgaard-Monch, K., B. T. Porse, and N. Borregaard. 2006. Systems
biology of neutrophil differentiation and immune response. Curr Opin
Immunol 18:54–60.
39. Utaisincharoen, P., N. Anuntagool, S. Arjcharoen, I. Lengwehasatit, K.
Limposuwan, P. Chaisuriya, and S. Sirisinha. 2004. Burkholderia 5
pseudomallei stimulates low interleukin-8 production in the human lung
epithelial cell line A549. Clin Exp Immunol 138:61–65.
40. van Zandbergen, G., J. Gieffers, H. Kothe, J. Rupp, A. Bollinger, E. Aga,
M. Klinger, H. Brade, K. Dalhoff, M. Maass, W. Solbach, and T. Laskay.
2004. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay 10
their spontaneous apoptosis. J Immunol 172:1768–1776.
41. van Zandbergen, G., M. Klinger, A. Mueller, S. Dannenberg, A. Gebert,
W. Solbach, and T. Laskay. 2004. Cutting edge: neutrophil granulocyte
serves as a vector for Leishmania entry into macrophages. J Immunol
173:6521–6525. 15
42. Visser, L. G., A. Annema, and R. van Furth. 1995. Role of Yops in
inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by
human granulocytes. Infect Immun 63:2570–2575.
43. White-Owen, C., J. W. Alexander, R. M. Sramkoski, and G. F. Babcock.
1992. Rapid whole-blood microassay using flow cytometry for measuring 20
neutrophil phagocytosis. J Clin Microbiol 30:2071–2076.
44. White, N. J. 2003. Melioidosis. Lancet 361:1715–1722.
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
24
Figure legends
Figure 1 Intracellular survival of B. pseudomallei in purified PMNs from
healthy and diabetic subjects. Purified PMNs from 6 healthy (A) and 4
diabetic (B) subjects were co-cultured with live B. pseudomallei at an 5
MOI 0.3:1 for 30 min and extracellular organisms were killed by 250
µg/ml kanamycin for another 30 min prior to lysing the cells for
bacterial count (T0). Intracellular bacteria were quantified by colony
plating at the indicated time points and presented as percentages (%) of
initial inoculums for individuals calculated from the number of 10
recovered bacteria/total added number of B. pseudomallei.
Figure 2 Phagocytosis of B. pseudomallei, S. Typhimurium or E. coli by human
PMNs. Whole blood leukocytes were incubated with medium alone or
FITC-conjugated live bacteria at an MOI 10:1 for 60 min and analyzed 15
by flow cytometry. PMNs were analyzed for phagocytosis by mean
fluorescent intensity (MFI) of FITC (A), phagocytosis by PMNs from
7 healthy (B) and 14 diabetic (C) subjects. P-value was calculated by
paired t test, * P < 0.05, ** P < 0.005, *** P < 0.0005. Bps-B.
pseudomallei, Sal-S. Typhimurium, DM-diabetes mellitus. The vertical 20
lines represent mean ± SE of the group.
Figure 3 Phagocytosis and oxidative burst of PMNs from healthy, well
controlled, and poorly controlled diabetic subjects. Whole blood
leukocytes of healthy vs. diabetic subjects were incubated with 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
25
medium alone, 800 ng/ml phorbol 12-myristate 13-acetate (PMA) or
FITC-conjugated live B. pseudomallei at an MOI 10:1 and analyzed by
flow cytometry. PMNs were analyzed for phagocytosis by MFI of
FITC-conjugated live B. pseudomallei and oxidative burst by MFI of
ethidium bromide or EB (A), phagocytosis of B. pseudomallei (B), 5
oxidative burst induced by PMA (C) or B. pseudomallei (D). P -value
was calculated by Mann Whitney test, * P < 0.05, ns-non significant,
(n)-number of subjects, DM-diabetes mellitus, HbA1c-glycosylated
hemoglobin A1c (good, poor and very poor glycemic control = 5.5–
7.5, 7.6–8.5 and above 8.5%, respectively). 10
Figure 4 Effect of B. pseudomallei on PMN migration in response to IL-8 of
healthy and diabetic subjects. Purified PMNs at 5 × 106 cells/ml of
healthy and diabetic subjects were examined for migration in a
transwell system in response to 20–100 ng/ml IL-8 (A) and the effect 15
of heat-killed B. pseudomallei on PMN migration responding to 100
ng/ml IL-8 by healthy (n = 5) (B) and diabetic (n = 5) subjects (C).
Transmigrated PMNs were counted by flow cytometry and migration
index was calculated as: number of transmigrated PMNs to IL-8/
number of transmigrated PMNs to medium control. DM-diabetes 20
mellitus, Hk-Bps-heat killed B. pseudomallei. P-value was calculated
by paired t test, * P < 0.05, ** P < 0.005.
Figure 5 PMN apoptosis in response to live B. pseudomallei of healthy and
diabetic subjects. PMNs were stained with annexin V-APC and 25
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
26
analyzed for time kinetics by flow cytometry at 0–24 h (A). Purified
PMNs were co-incubated in vitro with medium alone or live B.
pseudomallei at an MOI 1:1, at 37ºC for 1 h = T0 (B) and 24 h = T24
(C). Annexin V and propidium iodide (PI) staining on PMNs incubated
with heat-killed B. pseudomallei for 24h (D) and calculated for 5
apoptosis in response to medium alone or B. pseudomallei by %
annexin V+ PI- PMNs (E). P-value was calculated by paired t test, * P
< 0.05, ** P < 0.005, ns-non significant, Bps-B. pseudomallei.
10
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from
Table 1
General Characteristics of Healthy and Diabetic Subjects
General characteristic Healthy Diabetes mellitus
Subjects (n) 36 56
Male (n) 19 26
Female (n) 17 30
Age (years)* 45±8 53±8
Fasting blood glucose (mg/dl)* 80±12 151±69
Hemoglobin A1c (%)* 5.1±0.5 8.0±1.9
Serum creatinine (mg/dl)* 1.0±0.2 1.2±0.4
Note: n= number, * = mean ± SD.
ACCEPTED
on March 15, 2021 by guest
http://iai.asm.org/
Dow
nloaded from